It is reasonable to assume that obesity promotes the development of DCM via NOX4 participating in the immune response and ferroptosis by activating NADPH oxidase and NLRP3 inflammasomes. The gene discussed is FMO5; the disease is obesity due to melanocortin 4 receptor deficiency.